Here's What You Should Know About Pfizer's New COVID Drug

Joel S. Hirschhorn/Children's Health Defense - Opinion : Jan 3, 2022
LifeSiteNews.com

...Paxlovid requires combination with an HIV/AIDS drug, Ritonavir, preventing the breakdown of the Paxlovid so it may inhibit or decrease the enzyme, interrupting the viral life cycle. Ritonavir acts as a booster for Paxlovid, keeping it active inside a person's body. Ritonavir also has its own black box warning, and side effects include life-threatening liver, pancreas, and heart issues. Does the public really want to take an HIV/AIDS drug?...

[LifeSiteNews.com] The pro-drug industry mainstream media are insanely positive over the newly FDA approved Pfizer antiviral COVID treatment pills. (Image: Pixabay)

The drug, Paxlovid, received an emergency use authorization by FDA for use in patients 12 years old and up who have tested positive for COVID-19 and are at high risk.

Now is the time to speak calmly and accurately about Paxlovid. First, everyone should appreciate that there was very little testing of the short- and long-term safety of this product, exactly what happened with COVID vaccines. Really good testing of a new drug should take many months or even years.

All you get is positive news for this new drug—actually a combination of drugs.

Here are brief summary statements about this new product:

It was approved by the FDA without any external meetings, serious reviews of test data, or opportunity for public input. Pretty much all the regulatory work was done behind closed doors. Terrific for Pfizer. Bad for the public.

Of importance, note that in the trials only 21% of people had a comorbidity, while in reality 94% of COVID deaths have at least one comorbidity, and the average number of underlying medical conditions is four.

As to antiviral science, protease enzymes must be present for the virus to successfully infect by completing the cycle before taking the cell over. Paxlovid or any drug classified as a ‘Protease Inhibitor' will inhibit or decrease the protease enzyme, interfering with the virus. Paxlovid blocks the 3CLPro protease from chopping up the long protein into pieces. The virus can't separate out which pieces to cut out and assemble. It can't make copies of itself. The COVID infection quickly stops.

Contrary to what the government says, ivermectin is the most successful and proven protease inhibitor in use worldwide. Just as with Paxlovid, ivermectin decreases the protease enzyme but…there are benefits of ivermectin in COVID treatment that are not present in Paxlovid. Additional actions of ivermectin include anti-coagulant action and anti-inflammatory actions, both observed in COVID infections. And IVM has been safely used for decades and there have been many medical studies as well as clinical results showing its antiviral and anti-inflammatory effectiveness.

Paxlovid requires combination with an HIV/AIDS drug, Ritonavir, preventing the breakdown of the Paxlovid so it may inhibit or decrease the enzyme, interrupting the viral life cycle. Ritonavir acts as a booster for Paxlovid, keeping it active inside a person's body. Ritonavir also has its own black box warning, and side effects include life-threatening liver, pancreas, and heart issues. Does the public really want to take an HIV/AIDS drug?... Subscribe for free to Breaking Christian News here

Continue reading here.